PP2 inhibits glutamate release from nerve endings by affecting vesicle mobilization

Neuroreport. 2005 Nov 28;16(17):1969-72. doi: 10.1097/01.wnr.0000189758.57164.85.

Abstract

Src kinase is widely expressed in the brain and its inhibition with PP2 has previously been shown to depress depolarization-evoked glutamate release from rat cerebrocortical synaptosomes by reducing voltage-dependent Ca2+ entry. In this study, we further showed that the inhibitory effect of PP2 on 4-aminopyridine-evoked glutamate release results from a reduction of vesicular exocytosis and not from an inhibition of non-vesicular release. In addition, PP2 significantly inhibited ionomycin-induced or hypertonic sucrose-induced glutamate release. Also, disruption of cytoskeleton organization with cytochalasin D occluded the inhibitory action of PP2 on 4-aminopyridine and ionomycin-evoked glutamate release. These results suggest that PP2-mediated inhibition of glutamate release involves the modulation of some exocytotic steps, possibly through a regulation of actin cytoskeleton dynamics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / metabolism
  • Animals
  • Calcium / metabolism
  • Cytochalasin D / pharmacology
  • Enzyme Inhibitors / pharmacology
  • Exocytosis / drug effects
  • Glutamic Acid / metabolism*
  • Male
  • Nerve Endings / drug effects*
  • Nerve Endings / metabolism*
  • Nucleic Acid Synthesis Inhibitors / pharmacology
  • Pyrimidines / pharmacology*
  • Rats
  • Rats, Sprague-Dawley
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / metabolism
  • Synaptosomes / drug effects
  • Synaptosomes / metabolism
  • src-Family Kinases / antagonists & inhibitors*

Substances

  • AG 1879
  • Enzyme Inhibitors
  • Nucleic Acid Synthesis Inhibitors
  • Pyrimidines
  • Cytochalasin D
  • Glutamic Acid
  • src-Family Kinases
  • Calcium